About Appletree CI Group
Appletree CI Group is a company based in Winterthur (Switzerland) founded in 2013 was acquired by TFS in January 2023. Appletree CI Group offers products and services including Clinical Development, Resourcing Solutions, and Functional Services (FSP). Appletree CI Group operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
- Headquarter Winterthur, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Appletree CI Group
Appletree CI Group offers a comprehensive portfolio of products and services, including Clinical Development, Resourcing Solutions, and Functional Services (FSP).
Services for clinical trials from phases I-III
Flexible staffing for pharmaceutical projects
End-to-end clinical workforce management solutions
Funding Insights of Appletree CI Group
Detailed funding history for Appletree CI Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Appletree CI Group
Appletree CI Group has secured backing from 1 investor. Prominent investors backing the company include TFSCRO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical research services are provided globally by TFS CRO.
|
Locked | Locked | Locked |
Investor details for Appletree CI Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Appletree CI Group
Investment portfolio details for Appletree CI Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Appletree CI Group
Detailed financials for Appletree CI Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Appletree Ci Group Comparisons
Peer comparison for Appletree CI Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Appletree CI Group
Appletree CI Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Appletree CI Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Appletree Ci Group
Complete news archive for Appletree CI Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Appletree CI Group
Appletree CI Group was founded in 2013.
Appletree CI Group is headquartered in Winterthur, Switzerland. It is registered at Winterthur, Zurich, Switzerland.
Georg Mathis is the current CEO of Appletree CI Group.
Appletree CI Group is a contract research organisation serving the medical device, pharmaceutical and biotech industries. Service offering includes medical writing, biostatistics, legal representation, quality assurance, pharmacovigilance services, document management, clinical trial authorizations, and consulting. The company has operations in 9 European countries and also in therapeutic areas such as dermatology, paediatric investigations. The company was formed by the merger of Appletree AG and Clinical Investigations in April 2013. The merged company bought Brunner and Hess, a Swiss biostatistics and data management company in January 2014.
Appletree CI Group's top competitors include Emmes, Syneos Health and ClinChoice.
Appletree CI Group offers Clinical Development, Resourcing Solutions, and Functional Services (FSP).
Appletree CI Group has 1 investor. Key investors include TFSCRO.